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BACKGROUND: In 2006, to increase opportunities for
patients to become aware of their HIV status, the
Centers for Disease Control and Prevention released
updated guidelines for routine, opt-out HIV screening of
adults, adolescents, and pregnant women in healthcare
settings. To date, there are few documented applica-
tions of these recommendations.
OBJECTIVE: To measure the impact of application of
the guidelines for routine screening in health centers
serving communities disproportionately affected by
HIV in the southeastern US.
DESIGN: A multi-site program implementation study,
describing patients tested and not tested and assessing
changes in testing frequency before and after new
guidelines were implemented.
PARTICIPANTS: All patients aged 13 to 64 seen in
participating health centers.
INTERVENTIONS: Routine rapid HIV screening in
accord with CDC guidelines.
MEASUREMENTS: The frequency of testing before and
after routine screening was in place and demographic
differences in offering and receipt of testing.
MAIN RESULTS: Compared to approximately 3,000
patients in the year prior to implementation, 16,148
patients were offered testing with 10,769 tested. Of 39
rapid tests resulting in preliminary positives, 17 were
newly detected infections. Among these patients, 12 of
14 receiving referrals were linked to HIV care. Nineteen
were false positives. Younger patients, African Amer-
icans and Latinos were more likely to receive testing.
CONCLUSIONS: By integrating CDC-recommended
guidelines and applying rapid test technology, health
centers were able to provide new access to HIV testing.
Variation across centers in offering and receiving tests
may indicate that clinical training could enhance
universal access.
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INTRODUCTION
In 2006, the Centers for Disease Control and Prevention (CDC)
published updated recommendations for HIV testing of adults,
adolescents, and pregnant women in health care settings
1. The
recommendations aim to increase HIV screening of patients in
health care settings, detect unrecognized HIV infection earlier,
provide counseling and referrals to newly identified cases, and
reduce perinatal HIV transmission. One notable change is
the recommendation that HIV testing be offered on a routine
basis—a l lp a t i e n t sa g e d1 3t o6 4i nh e a l t h c a r es e t t i n g s
should be informed that they will be screened for HIV
infection unless they explicitly decline, regardless of signs,
symptoms or risk factors. This paper describes the results of
an effort to implement routine testing guidelines in six
community health centers in the Southeastern United States.
The national network of federally qualified community health
centers is a logical setting for implementation of the new guide-
lines. Health centers provide primary care and preventive
services,includingon-sitedental,pharmaceutical,mentalhealth
and substance abuse services, to the nation’s underserved.
Ninety-one percent of 18.4 million patients at health centers
seen in 2008 were low income; most (39%) were uninsured or
depended on Medicaid (35%). Two-thirds of patients are racial
andethnicminorities;abouthalfresideinruralareasandmostof
the rest live in inner-city communities.
2 Providing screening and
care for HIV is a priority in these settings because health center
patients are disproportionately affected by HIV.
The National Association of Community Health Centers, Inc.
(NACHC) is the non-profit member organization providing a
common source for research, information, training and advo-
cacy for 6,300 federally qualified community health centers in
the US and its territories. In 2004, NACHC launched the
Putting Patients First: Health Centers as Leaders in HIV
Prevention and Testing initiative in partnership with the CDC
and the US Bureau of Primary Health Care. The initiative aims
to increase the number of patients receiving HIV testing and
prevention services during routine health care visits. Because
NACHC was already working to enhance access to HIV testing
when the new guidelines were released, NACHC was able to
leverage existing momentum. NACHC trainers were able to
design and implement a model in accord with guidelines which
could help health centers integrate routine screening into their
primary care programs.
This paper describes an evaluation of the effort to make HIV
screening routine in selected health centers, which is partic-
ularly important because we are aware of only one published
study reflecting the outcomes of implementation in this type of
setting.
3 We present the following: 1) the number of tests
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1269delivered before and after implementing routine testing; 2) the
frequency with which testing was offered to eligible patients
seen during the study period; 3) the frequency with which tests
were performed; 4) the frequency with which cases were
identified, and; 5) demographic characteristics of patients
offered and receiving tests.
METHODS
Setting. Participation was open to all community health centers
not receiving categorical HIV-funding (from the federal Ryan
White Program) in North Carolina, South Carolina and
Mississippi. NACHC worked with primary care associations in
each state to identify health centers that were highly motivated
to implement routine HIV screening. Community health
centers are often comprised of more than one clinical site,
which was the case with all but one of the six centers
participating in this effort. Participating centers did not
receive any additional funding to support their transition to
routine HIV testing, although rapid test kits were donated, and
later in the project year, a small stipend from NACHC was
provided to support confirmatory testing. Health centers began
rolling out testing between December 2006 and April 2007 and
submitted test documentation data for this study through
March 31, 2008. For this analysis, we restricted data to the 13-
month period between March 1, 2007 and March 31, 2008
when full implementation was underway. Institutional Review
Board approval for the analysis was obtained from the
University of California, San Francisco.
HIV Testing Algorithm. The HIV testing algorithm was developed
by the NACHC trainer after consulting with participating
health centers and was included in the overall written
protocol used in each clinic. Trained clinical staff members
drew blood samples using a finger stick method. Samples were
tested using the Uni-Gold Recombigen HIV screening test
(Trinity Biotech USA, St. Louis, MO). Clinical staff reported
negative results to patients as HIV-uninfected; positive results
were reported as preliminary positive and staff gave patients
written information about the nature of the result. At that
time, patients were offered confirmatory testing, which was
done with a western blot. If the western blot was negative,
clinic staff asked patients to return after three months for a
repeat western blot. Late in the year of implementation,
NACHC was able to find some funding for two centers to
conduct RNA testing in lieu of western blots.
Clinic Procedures. After participating health centers were
identified, the NACHC trainer worked with staff in each clinic
to redesign patient flow procedures to integrate routine HIV
screening with the primary care visit. Although the point in the
visit when testing was offered differed across centers, in
general, non primary care providers conducted the testing
and delivered results when the test came back negative. In
cases of preliminary positive results, a primary care provider
delivered the result. Clinic-specific procedures were
documented in written protocols, which were used during
clinic-wide in-service and role-specific training for primary
care providers, social workers, and nurses. Training topics
included how to offer HIV screening, discuss rapid test results,
document testing and link HIV-infected patients to follow-up
care. Training was integrated into centers’ pre-existing meeting
schedules where possible. The NACHC trainer provided
intensive on-site technical assistance during start-up, with
ongoing support provided via email, telephone and periodic
follow-up visits. Patient education materials were also
developed in English and Spanish using health literacy
principles.
4 A more detailed description of the model
including the barriers and facilitators experienced during
implementation of this project is available elsewhere.
5
Data used to determine HIV Tests Offered and Inclusion
and Exclusion Criteria for the Study. To help understand the
results of the project, we used two data sets reflecting
application of new procedures. First, we used administrative
data reported by all centers through a uniform data system.
From this dataset, we obtained the aggregate number of
patients seen during the study period. We compared these
figures to the number of patients to whom tests were offered,
determined from the second data set: de-identified patient-level
documentation of tests provided by clinics, which used a
standard form developed for this project. We stratified by
health center to measure variation across them. We included
patients in this analysis if their age was inside the range for
which testing guidelines are established.
HIV Tests Performed. Patient-level data was used to determine
the number of tests offered and performed by each health
center during the study period. To measure changes in the
percent of patients tested before and after procedures were
implemented, health centers provided the total number of
patients seen and tests performed in the year prior to the study
(2006). We compared this to tests offered during the study
period, calculated from the patient-level data set.
Identification of New HIV Cases and Linkage to Care. We also
used patient-level data to determine test outcomes (negative or
preliminary positive) and whether reactive tests were confirmed
with western blots. In cases of confirmed infection, we asked
health centers to indicate if patients were successfully linked to
HIV care.
Characteristics of Patients Offered HIV Screening. To determine
if there weredifferences in characteristics of all patients seenand
those offered HIV screening, we combined the patient-level
testing documentation into categories matching the pre-
aggregated administrative dataset and compared the two.
Categories of comparison include patient data by age and
gender, race/ethnicity and insurance status. We used
unadjusted odds ratios and 95% confidence intervals to
measure significant differences across categories.
Characteristics of Patients Tested. To determine if there were
differences in characteristics of patients offered and receiving
tests, we used the patient-level data to perform univariable
and multivariable logistic regression. We observed different
relationships between an overall model to assess differences in
1270 Myers et al.: Routine HIV Screening in Community Health Centers JGIMtesting and separate models for women and men. Therefore, we
assessed differences in testing by categories of age, race/
ethnicity and insurance status variables, controlling for the
health center in which a patient was seen, among women and
among men.
RESULTS
Frequency of Offering Routine HIV Screening. During the study
period, 16,148, or 28%, of patients between 13 and 64 were
offered HIV tests (Table 1); the percentage varied across health
centers from 7% to 50%.
Frequency of HIV Tests Performed. Of the tests offered, 10,769
(67%) were performed (with a range from 56% to 83% across
health centers; Table 1). Compared to the year prior to the
study, when 3,078 tests (approximately 3% of patients) were
performed, this represented an almost three-fold increase in
the number of tests performed.
Identification of New HIV Cases and Linkage to Care. The
number of newly confirmed HIV-infections is presented in
Table 1. Of tests performed, 39 (0.36%) yielded preliminary
positive results; of these, 17 (0.16%) were confirmed HIV
infections. Health centers reported that 14 of the 17 were
offered referral to HIV specialty care with 12 accepting that
referral. Five (29% of preliminary positive results) were
determined to be false positives with either two western blot
tests or RNA testing. Eleven additional patients received only
one confirmatory western blot test and all tested negative. One
individual did not receive confirmatory testing.
Characteristics of Patients Offered HIV Screening. Table 2
compares all patients seen during the study period to
patients offered testing. Patients under 55, and particularly
men under 18 (OR=0.34; 95% CI=0.30, 0.38, p<0.0001) were
less likely to be offered testing. Compared to whites, Latinos
(OR=0.38; 95% CI=0.36, 0.40, p<0.0001) and patients of
races/ethnicities other than white, Latino and African
American were less likely to be offered testing (OR=0.17; 95%
CI=0.15, 0.19, p<0.0001). African Americans were more likely
than whites to be offered testing (OR=1.06; 95% CI=1.01,
1.11, p<0.0001). Although testing was offered free of charge,
compared to uninsured patients, patients with Medicaid and
Medicare were less likely to be offered testing and patients with
private insurance were more likely to be offered it (all p<
0.0001). Women were no more or less likely to be offered
testing than were men.
Characteristics of Patients Tested. Tables 3 and 4 present the
predictors of receipt of an HIV test across demographic
characteristics and gender, controlling for health center.
Among men and women, patients offered testing aged 54 and
younger—and especially those aged 18 to 34—were
significantly more likely to test compared to those aged 55
and over. Among both men and women, patients who were not
white – and particularly Latinos - were more likely to receive
testing when it was offered. Regardless of the health center
where they were seen, age and insurance status, compared to
white men (Table 3), Latino men were more than twice as likely
to receive testing when it was offered (OR=2.72; 95% CI=2.27,
3.25; p<0.0001). Latinas (Table 4) were over twice as likely to
receive testing as their white counterparts (OR=2.18; 95% CI=
1.92, 2.47; p<0.0001). With regard to health insurance, after
controlling for demographics and health center, only privately
insured men were slightly less likely to receive testing
compared to uninsured men (OR=0.82; 95% CI=0.70, 0.97;
p<0.0001).
DISCUSSION
In community health centers prepared for and motivated to
implement routine HIV testing, implementation of expanded
HIV screening is providing important new access for health
center patients. Among patient offered screening in participat-
ing health centers, as many as 83% were tested. While not all
patients were tested, this project demonstrated that with a well
developed protocol, access to test kits, training and support,
primary care clinics in community settings could implement
and sustain expanded access to HIV testing. This approach is
receiving renewed attention as a key strategy in the fight
against HIV.
6
The proportion of patients tested as a result of this effort
was comparable or greater than what has been found in other
studies.
7–11 Nevertheless, variation in the rates of offering and
Table 1. Number and Percentage of Persons Tested for Human Immunodeficiency Virus (HIV) in Community Health Centers by Site and














Unduplicated patients aged 13
to 64 seen at health centers
6,716 2,632 6,345 9,906 28,396 4,624 58,619
Documented offer of HIV testing
(% of total patients)
2,850 (42%) 179 (7%) 3,150 (50%) 2,364 (24%) 5,470 (19%) 2,135 (46%) 16,148 (28%)
Received HIV testing (% of
those offered)
2,379 (83%) 124 (69%) 1,764 (56%) 1,464 (62%) 3,808 (70%) 1,230 (58%) 10,769 (67%)
Preliminarily Positive Rapid
Test Result (% of tests)
16 (0.67%) 1 (0.81%) 2 (0.11%) 6 (0.41%) 13 (0.34%) 1 0.08%) 39 (0.36%)
Confirmed as newly diagnosed
HIV-infected (% of tests)
8 (0.34%) 0 0 2 (0.14%) 6 (0.16%) 1 (0.08%) 17 (0.16%)
Linked to care (% of newly
confirmed HIV-infected)
7 N/A N/A 1 6 0 14
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project may mean that the degree to which all patients receive
screening depends on the setting in which testing is offered. We
did not directly assess reasons why patients were or were not
offered testing. It may be that some patients and providers in
the mostly rural health centers participating in this effort do
not perceive HIV as a problem in their communities. In a 2003
survey (unpublished; Executive Summary available from
NACHC), health centers reported this perception to be a
barrier to testing. The rate of offering tests that we found may
also reflect competing priorities in health centers. As a main
site of primary care in many communities, other health
conditions such as diabetes and heart disease, which are more
prevalent than HIV infection, may be the priority.
Demographic differences among patients offered and not
offered tests may reflect the role of provider-related factors—
such as comfort with different patients or perceptions of patient
risk or need—in expanding HIV screening. Latinos in particular
were less likely to be offered testing; this may have been a
language issue. Older patients were more likely to be offered
testing, perhaps because they had establishedrelationships with
the centers and providers working in them. In any case, these
Table 2. Number and Percentage of Patients Eligible for Screening and Offered Screening – March 1, 2007 to March 31, 2008
All patients Patients offered screening
a Unadjusted odds ratio 95% confidence intervals
N N % of all patients
Gender
All males 19,898 5,496 28% 1.01 0.97, 1.05
All females 38,721 10,636 27% Reference
Gender and age
Males
13 to 17 2,774 414 15% 0.34 0.30, 0.38
18 to 34 6,813 1,733 25% 0.65 0.59, 0.72
35 to 54 7,290 2,312 32% 0.89 0.81, 0.97
55 to 64 3,021 1,037 34% Reference
Females
13 to 17 3,426 706 21% 0.49 0.44, 0.54
18 to 34 16,839 3,870 23% 0.56 0.82, 0.60
35 to 54 13,886 4,468 32% 0.89 0.83, 0.95
55 to 64 4,570 1,592 35% Reference
Race
African American 17,733 6,546 37% 1.06 1.01, 1.11
Latino 21,966 3,812 17% 0.38 0.36, 0.40
White 14,995 5,334 36% Reference
Other 4,838 414 9% 0.17 0.15, 0.19
Insurance
Uninsured 26,582 9,423 35% Reference
Medicaid 6,900 2,107 31% 0.80 0.76, 0.85
Medicare 4,064 876 22% 0.50 0.46, 0.54
Private Insurance 7,202 2,714 38% 1.10 1.04, 1.16
aTotals within categories may not sum to 100% due to missing data; in the case of insurance, we omitted ‘other insurance’.
Note: Odds ratios in bold are p<0.0001
Table 3. Predictors of Patient Receipt of HIV Test—Results of Univariable and Multivariable Analysis for Men Aged 13 to 64
MEN





Offered test (n=5,496) Received test (n=3,603; 66%)
a
Age
13 to 17 414 287 (69%) 1.90 (1.49, 2.41) 1.38 (1.03, 1.84)
18 to 34 1,733 1,253 (72%) 2.19 (1.86, 2.57) 1.60 (1.32, 1.94)
35 to 54 2,312 1,449 (63%) 1.41 (1.21, 1.63) 1.23 (1.03, 1.46)
55 to 64 1,037 564 (54%) Reference Reference
Race
African American 2,016 1,384 (69%) 2.21 (1.94, 2.53) 1.55 (1.31, 1.84)
Latino 1,482 1,134 (77%) 3.29 (2.83, 3.83) 2.72 (2.27, 3.25)
White 1,825 908 (50%) Reference Reference
Other 164 122 (74%) 2.91 (2.03, 4.18) 2.31 (1.57, 3.38)
Insurance
Uninsured 3,182 2,140 (67%) Reference Reference
Medicaid 509 327 (64%) 0.87 (0.72, 1.05) 0.86 (0.70, 1.06)
Medicare 401 233 (58%) 0.65 (0.53, 0.81) 0.96 (0.77, 1.21)
Private insurance 967 627 (65%) 0.85 (0.73, 0.99) 0.82 (0.70, 0.97)
aTotals within categories may not sum to 100% due to missing data; in the case of insurance, we omitted ‘other insurance’.
bOdds ratios are adjusted for demographic characteristics, insurance status and health center in which patients were seen.
Note: Odds ratios in bold are p<0.0001
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capacity-building including support for developing models which
are tailored to specific clinic settings. It also may be that as
healthcare providers become more comfortable with routine
screening procedures, some of the differences will disappear in
the demographicsof patientsoffered and notoffered testing. Next
steps for providers working in community health centers – and
others – who want to make HIV screening more accessible will be
to refine tools and training strategies to facilitate more consistent
testing.
Differences in receipt of testing when it is offered may be due
to patient-related factors. African Americans and Latinos may
be more likely to accept provider’s suggestions in general, or it
may be that non-whites are more likely to accept testing
because they are aware of higher HIV infection rates among
people of color. Younger people were also more likely to accept
testing, which may reflect self-perceived risk. These results
suggest that tailored information should be provided to
patients to assure accurate perceptions of risk and the value
of HIV testing.
This project was successful in finding new infections and in
linking patients to care that they would not otherwise have
received. Although the number of newly detected infections
was smaller than anticipated, it may not be reflective of the
prevalence among all patients since there may be more
undetected infections among the patients who were not tested.
Nevertheless, health centers did find a prevalence of infections
exceeding the threshold that the CDC recommends for contin-
ued testing
1 and health center staffs hope to test the more
reluctant patients as the program proceeds.
Another unanticipated finding was that most preliminarily
positive rapid tests resulted in unconfirmed infections. While
the proportion of false positives in this sample mirrors that of
other studies in similar settings
12 and the rate was in accord
with the manufacturer’s findings for specificity in low preva-
lence populations,
13 providers found this disconcerting. At the
beginning stages of implementation, clinic staff did not always
have well-developed contingency plans for reactive tests.
However, as the number of unconfirmed reactive tests grew,
providers and staff understood more clearly the importance of
communicating the uncertainty around preliminary positive
results and of confirmatory testing. Health centers carefully
considered the issue of false positives and designed procedures
to protect patients; they developed patient information on what
a preliminary positive result meant and provided careful and
comprehensive counseling to all patients whose screening test
resulted in a preliminary positive. Health centers learned that
false positive results are not benign and patient satisfaction
and protection should be considered alongside accuracy. In
this case and in future efforts, clarifying procedures and
understanding how to cope with the possible outcomes of a
reactive test will be important to sustaining efforts. Patients
and providers may also benefit from new testing technologies
and algorithms such as those using multiple rapid tests at one
time to improve performance.
14–15
New algorithms also may mitigate the challenges introduced
with longer wait times for confirmatory test results. In this
project, many patients did not return for the results of their
second test. In one case, the patient chose to forego confirma-
tory testing altogether. With wait times for confirmed infection,
linkages to care were suboptimal. Even when health centers
had active, well-established referral systems in place, patients
were less likely to be linked to care when they did not return for
confirmatory testing. Centers without well-defined referral
networks had even more difficulty ensuring follow-up care.
Keeping the referral systems timely, patient-centered and
comprehensive has been critical. Health centers learned that
referral networks are important, and that HIV testing pro-
grams require effort and resources devoted specifically to
ensuring patients are linked to care.
Our evaluation of this effort has some limitations. We were
only able to obtain aggregate data for the reference popula-
tions, which may have precluded us from discovering addi-
tional variables influencing the offering of tests. Because of
time and staff resource constraints, we do not have reliable
information about why patients did not test nor do we
understand why the variation across health centers was so
great. It may be that factors related to the specific clinic or
Table 4. Predictors of Patient Receipt of HIV Test—Results of Univariable and Multivariable Analysis for Women Aged 13 to 64
WOMEN





Offered test (n=10,636) Received test (n=7,292, 69%)
a
Age
13 to 17 706 499 (71%) 1.79 (1.48, 2.16) 1.54 (1.25, 1.90)
18 to 34 3,870 2,846 (74%) 2.06 (1.82, 2.33) 1.81 (1.57, 2.09)
35 to 54 4,468 2,955 (66%) 1.45 (1.29, 1.63) 1.32 (1.16, 1.50)
55 to 64 1,592 914 (57%) Reference Reference
Race
African American 4,528 3,222 (71%) 1.83 (1.66, 2.00) 1.84 (1.66, 2.04)
Latino 2,329 1,796 (77%) 2.49 (2.22, 2.80) 2.18 (1.92, 2.47)
White 3,509 2,018 (58%) Reference Reference
Other 250 162 (65%) 1.35 (1.03, 1.77) 1.34 (1.01, 1.78)
Insurance
Uninsured 6,239 4,252 (68%) Reference Reference
Medicaid 1,597 1,108 (69%) 1.03 (0.92, 1.16) 1.07 (0.94, 1.21)
Medicare 475 290 (61%) 0.70 (0.58, 0.84) 0.92 (0.76, 1.13)
Private insurance 1,750 1,226 (70%) 1.05 (0.93, 1.18) 1.09 (0.96, 1.23)
aTotals within categories may not sum to 100% due to missing data; in the case of insurance, we omitted ‘other insurance’.
bOdds ratios are adjusted for demographic characteristics, insurance status and health center in which patients were seen.
Note: Odds ratios in bold are p<0.0001
1273 Myers et al.: Routine HIV Screening in Community Health Centers JGIMcommunity influenced rates of offering and accepting tests;
these factors warrant further study.
Community health centers were able to expand the access
that their patients have to HIV testing. Over time, we anticipate
that HIV screening will become seamlessly integrated into
primary care in these settings and that access will become
more consistent for all patients. This project demonstrates
what routine screening looks like in real world settings; with
commitment and effort, health centers successfully integrated
routine screening into primary care settings.
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